2025-08-01 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided. The report is in English, includes key numbers, and offers some analysis and context.

## Albemarle Corp (ALB) Stock Analysis

**Company Overview:** Albemarle Corp is a specialty chemicals company focused on lithium, bromine specialties, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** -7.71%
*   **VOO Cumulative Return:** 83.19%
*   **Divergence:**
    *   Current: -81.6
    *   Min: -90.2
    *   Max: 312.9
    *   Relative Divergence: 2.1

**Analysis:** Albemarle has significantly underperformed the S&P 500 over the period covered. The current divergence is -81.6%, indicating substantial underperformance compared to VOO. The relative divergence of 2.1 suggests that the underperformance is near the lower end of its historical range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha     | Beta     | Cap(B) |
|------------|----------|-------|-----------|----------|--------|
| 2015-2017  | -4.0%    | 0.0%  | -6.0%     | 2.1      | 15.1   |
| 2016-2018  | -31.0%   | 57.3% | -27.0%    | -0.0     | 9.1    |
| 2017-2019  | -26.0%   | 57.3% | -49.0%    | -0.0     | 8.6    |
| 2018-2020  | 104.0%   | 62.7% | 77.0%     | -0.0     | 17.4   |
| 2019-2021  | 214.0%   | 62.7% | 165.0%    | -0.1     | 27.5   |
| 2020-2022  | 187.0%   | 75.6% | 181.0%    | -0.0     | 25.5   |
| 2021-2023  | -32.0%   | 77.5% | -52.0%    | 0.5      | 17.0   |
| 2022-2024  | -145.0%  | 77.5% | -172.0%   | 0.9      | 10.1   |
| 2023-2025  | -248.0%  | 77.5% | -296.0%   | 0.5      | 8.0    |

**Analysis:**

*   **CAGR & MDD:** The CAGR (Compound Annual Growth Rate) shows significant volatility across different periods. High MDD (Maximum Drawdown) figures indicate substantial risk and potential losses.
*   **Alpha:** Negative Alpha values in most periods suggest the stock has underperformed its benchmark (risk-adjusted).
*   **Beta:** Beta values close to zero indicate that the stock's price is not highly correlated with the market.
*   **Cap(B):** Market capitalization has varied over the years.

### 2. Recent Price Action

*   **Current Price:** $67.85
*   **Previous Close:** $68.89
*   **Change:** -1.51
*   **5-Day Moving Average:** 73.37
*   **20-Day Moving Average:** 73.73
*   **60-Day Moving Average:** 64.5267

**Analysis:** The stock is trading below its 5-day and 20-day moving averages, suggesting a short-term downtrend. However, it is above its 60-day moving average, indicating some longer-term support. The negative change of -1.51 from the previous close is a short term down trend.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3295 (Low Risk)
*   **RSI:** 46.29 (Neutral)
*   **PPO:** -1.95 (Negative)
*   **Hybrid Signal:** cash_70%_Sell (70% of holdings)
*   **Recent (20-Day) Relative Divergence Change:** -3.4 (Negative - Short-Term Decline)
*   **Expected Return:** 5493.3% (Long-Term, vs. S&P 500)

**Analysis:**

*   The MRI indicates Low Risk.
*   The RSI is close to neutral, not indicating overbought or oversold conditions.
*   The negative PPO suggests a potential downward trend in price momentum.
*   The Hybrid Signal recommends selling 70% of holdings due to the risk conditions.
*   The negative change in relative divergence confirms a recent short-term decline relative to the S&P 500.
*   The extremely high expected return should be viewed with skepticism. Such a high return is unlikely and could be the result of a model overfitting historical data or unrealistic assumptions.

### 4. Recent News & Significant Events

*   **2025-07-29:** Major business developments, regulatory changes, or market events.
*   **2025-07-28:** Analyst discussions on recent performance and outlook in context of industry trends and global economic factors.
*   **2025-08-01:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-31:** Market experts highlight both risks and opportunities.

**Analysis:** The recent news indicates that Albemarle is experiencing volatility and is subject to significant market and industry scrutiny. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-04-30   | 0     | 1.08 B$   |
| 2024-11-06   | -9.45 | 1.35 B$   |
| 2024-07-31   | -1.96 | 1.43 B$   |
| 2024-05-01   | -0.08 | 1.36 B$   |
| 2025-04-30   | -0.08 | 1.36 B$   |

**Analysis:** The EPS (Earnings Per Share) has been negative for several quarters, indicating unprofitability. The revenue has fluctuated but shows a general decline.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $1.08B  | 14.51%        |
| 2024-12-31 | $1.23B  | 11.22%        |
| 2024-09-30 | $1.35B  | -7.68%        |
| 2024-06-30 | $1.43B  | -0.74%        |
| 2024-03-31 | $1.36B  | 2.86%         |

**Capital and Profitability:**

| Quarter    | Equity   | ROE       |
|------------|----------|-----------|
| 2025-03-31 | $10.03B | 0.41%     |
| 2024-12-31 | $9.96B  | 0.76%     |
| 2024-09-30 | $10.24B | -10.44%   |
| 2024-06-30 | $11.22B | -1.68%    |
| 2024-03-31 | $11.53B | 0.02%     |

**Analysis:**

*   **Revenue and Profitability:** Revenue has declined over the past few quarters, with negative profit margins in some quarters. This suggests cost management issues or decreased demand for Albemarle's products.
*   **Capital and Profitability:** Equity has decreased, and ROE (Return on Equity) has been generally low or negative, indicating poor returns relative to shareholder equity.

### 7. Overall Analysis and Recommendations

Albemarle Corp (ALB) is facing several challenges:

*   **Underperformance:** Significant underperformance compared to the S&P 500.
*   **Volatility:** High volatility and negative recent price action.
*   **Unprofitability:** Negative EPS and declining revenue.
*   **Financial Health:** Declining equity and poor ROE.

The Hybrid Signal's recommendation to sell 70% of holdings reflects the current risk environment.

**Recommendation:** Given the current data, a cautious approach is warranted. It would be prudent to reduce exposure or avoid new positions in ALB until there are clear signs of a turnaround in profitability and market sentiment. Closely monitor news related to earnings, regulatory changes, and market events that may impact the company's future performance. The long-term expected return should be viewed with caution.
